Patient considerations
Before prescribing LATISSE® to your patients with eyelash hypotrichosis,
discuss ocular health with those who have or have had a history of the following1:
-
Previously diagnosed with eye pressure problems Patients who have
been previously diagnosed with elevated intraocular pressure (IOP) or have a history
of elevated IOP should speak to an eye care specialist prior to starting LATISSE®
solution.
-
Currently on IOP-lowering medications Patients who are currently
using IOP-lowering medications should speak with an eye care specialist prior to
starting LATISSE® solution.
-
Have risk factors for or were previously diagnosed with glaucoma
Patients with risk factors for glaucoma or a family history of glaucoma should speak
to an eye care specialist prior to starting LATISSE®.
-
Currently pregnantThere are no adequate and well-controlled studies
of bimatoprost ophthalmic solution 0.03% administration in pregnant women. Because
animal reproductive studies are not always predictive of human response, LATISSE®
should be administered during pregnancy only if the potential benefit justifies
the potential risk to the fetus.
-
Nursing mothers It is not known whether LATISSE®
solution is excreted in human milk, although in animal studies, bimatoprost has
been shown to be excreted in breast milk. Because many drugs are excreted in human
milk, caution should be exercised when LATISSE® is administered to
a nursing woman.
-
Pediatric use Safety and effectiveness in pediatric patients have
not been established.
-
Have risk factors for macular edema LATISSE® solution
should be used with caution in aphakic patients, in pseudophakic patients with a
torn posterior lens capsule, or in patients with known risk factors for macular
edema.
What to expect with LATISSE®
Manage expectations with growth timelines